Correction of ADAMTS13 Deficiency by AAV-Mediated Gene Transfer of a C-Terminal Truncated ADAMTS13 Variant In a Murine Model

被引：0
|
作者：
Jin, Sheng-Yu
Xiao, Juan
Wright, J. Fraser
Zheng, X. Long
机构：
[1] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [41] Regulation of VWF Cleavage Is Mediated By Coupling ADAMTS13 D- and C- Domain Binding Sites
    Muia, Joshua
    Barton, J. Cameron
    Smith, Kathryn L.
    Vanhoorelbeke, Karen
    Manukonda, Veera V.
    Platt, Anna
    Miranda, Frida
    BLOOD, 2022, 140 : 5580 - 5581
  • [42] A C-terminal exosite of von Willebrand factor domain A2 interacts with ADAMTS13 spacer domain to accelerate substrate cleavage.
    Gao, Weicliang
    Anderson, Patricia J.
    Majerus, Elaine M.
    Tuley, Elodee A.
    Sadler, J. Evan
    BLOOD, 2006, 108 (11) : 507A - 507A
  • [43] Non-sense-mediated mRNA decay in ADAMTS13 Gene.Caused by 29 nucleotide deletion.
    Garagiola, Isabella
    Lavoretano, Silvia
    Oren, Hale
    Bohm, Martina
    Mannucci, Pier Mannuccio
    Peyvandi, Flora
    BLOOD, 2006, 108 (11) : 316A - 316A
  • [44] Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome
    Arumugam, Venkatesh
    Bhowmick, Rohit
    Agarwal, Indira
    Arumadi, Manjusha
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2019, 30 (03) : 701 - 705
  • [45] Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura
    Zhu, Meng-Lei
    Reeves, Hollie M.
    Maitta, Robert W.
    THROMBOSIS RESEARCH, 2021, 198 : 72 - 78
  • [46] Alterations in von Willebrand Factor and ADAMTS13 Lead to Thrombosis and Organ Injury in a Murine Trauma-Hemorrhage-Resuscitation Model
    Russell, Robert T.
    He, Lan
    Zhang, Di
    Evans, Cilina
    Cao, Wenjing
    Kocher, Nicole K.
    Zheng, X. L.
    Pittet, Jean F.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : E60 - E60
  • [47] Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman's disease: A case report
    Lopes Benevides, Thais Celi
    Orsi, Fernanda Andrade
    Colella, Marina Pereira
    Percout, Priscila de Oliveira
    Moura, Muriel Silva
    Dias, Maria Almeida
    Lins, Betina Diniz
    de Paula, Erich Vinicius
    Vassallo, Jose
    Annichino-Bizzachi, Joyce
    PLATELETS, 2015, 26 (03) : 263 - 266
  • [48] A Single Synonymous Variant (c.354G>A [p.P118P]) in ADAMTS13 Confers Enhanced Specific Activity
    Hunt, Ryan
    Hettiarachchi, Gaya
    Katneni, Upendra
    Hernandez, Nancy
    Holcomb, David
    Kames, Jacob
    Alnifaidy, Redab
    Lin, Brian
    Hamasaki-Katagiri, Nobuko
    Wesley, Aaron
    Kafri, Tal
    Morris, Christina
    Bouche, Laura
    Panico, Maria
    Schiller, Tal
    Ibla, Juan
    Bar, Haim
    Ismail, Amra
    Morris, Howard
    Komar, Anton
    Kimchi-Sarfaty, Chava
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [49] Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood Cells Expressing Fragments of ADAMTS13 on Their Membrane
    Roberts, Karl
    Yan, Zi
    Zhang, Shouping
    Olivier, Emmanuel
    Batbayar, Khulan
    Bouhassira, Eric E.
    BLOOD, 2023, 142
  • [50] Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy
    Verhenne, Sebastien
    Vandeputte, Nele
    Pareyn, Inge
    Izsvak, Zsuzsanna
    Rottensteiner, Hanspeter
    Deckmyn, Hans
    De Meyer, Simon F.
    Vanhoorelbeke, Karen
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (05) : 836 - +
12345